Paper114397
Pharmacokinetics of cyclophosphamide after prolonged low dose treatment in ovarian cancer patients.
D'Incalci M and 4 others. Eur J Drug Metab Pharmacokinet, 1979. Cited by 4 papers, by iCite.
Cite this record
ConductScience Library. Pharmacokinetics of cyclophosphamide after prolonged low dose treatment in ovarian cancer patients. Papers, record 114397. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/114397
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Pharmacokinetics of cyclophosphamide after prolonged low dose treatment in ovarian cancer patients.
- PubMed
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cyclophosphamide | Major topic |
| Ovarian Neoplasms | Major topic |
| Dose-Response Relationship, Drug | |
| Female | |
| Half-Life | |
| Humans | |
| Kinetics | |
| Long-Term Care | |
| Pregnancy |
Source PubMed
References13
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 4479366 | The biotransformation of cyclophosphamide in man: analysis of the variation in normal subjects. | Acta Pharmacol Toxicol (Copenh) | 1974 | https://conductscience.org/library/papers/4479366 | PubMed |
| 2 | 4393764 | Enzymatic basis of cyclophosphamide activation by hepatic microsomes of the rat. | J Pharmacol Exp Ther | 1970 | https://conductscience.org/library/papers/4393764 | PubMed |
| 3 | 1131393 | Isolation and mass spectral identification of blood metabolites of cyclophosphamide: evidence for phosphoramide mustard as the biologically active metabolite. | Biomed Mass Spectrom | 1975 | https://conductscience.org/library/papers/1131393 | PubMed |
| 4 | 13700518 | Studies on the mechanism of action of cytoxan. Evidence of activation in vivo and in vitro. | Cancer Res | 1961 | https://conductscience.org/library/papers/13700518 | PubMed |
| 5 | 5570713 | Drug metabolism after repeated treatments with cytotoxic agents. | Eur J Cancer (1965) | 1971 | https://conductscience.org/library/papers/5570713 | PubMed |
| 6 | 649726 | Simple and sensitive method for the determination of cyclophosphamide by means of a nitrogen--phosphorus-selective detector. | J Chromatogr | 1978 | https://conductscience.org/library/papers/649726 | PubMed |
| 7 | 1277205 | Comparative pharmacologic study in vitro and in vivo with cyclophosphamide (NSC-26271), cyclophosphamide metabolites, and plain nitrogen mustard compounds. | Cancer Treat Rep | 1976 | https://conductscience.org/library/papers/1277205 | PubMed |
| 8 | 5157730 | Pharmacokinetics of cyclophosphamide in man. | Br J Pharmacol | 1971 | https://conductscience.org/library/papers/5157730 | PubMed |
| 9 | 5014778 | Enzymatic metabolism of cyclophosphamide and nicotine and production of a toxic cyclophosphamide metabolite. | Cancer Res | 1972 | https://conductscience.org/library/papers/5014778 | PubMed |
| 10 | 4811053 | Some studies of the active intermediates formed in the microsomal metabolism of cyclophosphamide and isophosphamide. | Biochem Pharmacol | 1974 | https://conductscience.org/library/papers/4811053 | PubMed |
| 11 | 954793 | Continuous low-dose cyclophosphamide (NSC-26271) therapy in advanced ovarian cancer. | Eur J Cancer (1965) | 1976 | https://conductscience.org/library/papers/954793 | PubMed |
| 12 | 14208670 | [ON THE ACTIVATION OF CYCLOPHOSPHAMIDE IN VIVO AND IN VITRO]. | Arzneimittelforschung | 1963 | https://conductscience.org/library/papers/14208670 | PubMed |
| 13 | 4397323 | Metabolism of cyclophosphamide by rat hepatic microsomes. | Cancer Res | 1971 | https://conductscience.org/library/papers/4397323 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 23143218 | Phase I and clinical pharmacology study of bevacizumab, sorafenib, and low-dose cyclophosphamide in children and young adults with refractory/recurrent solid tumors. | Clin Cancer Res | 2013 | https://conductscience.org/library/papers/23143218 |
Source PubMed
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/114397
GET https://conductscience.org/api/papers/v1/114397/authors